Open AccessPermanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine
Author(s) -
Vannini S.D. P.,
Truttmann A. C.,
Bianchetti M. G.,
Vannini S. D. P.,
Mazzola B. L.,
Rodoni L.,
Ferrari P.,
Wermuth B.,
Bianchetti M. G.
Publication year - 1999
Publication title -
transplant international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.998
H-Index - 82
eISSN - 1432-2277
pISSN - 0934-0874
DOI - 10.1111/j.1432-2277.1999.tb01208.x
Subject(s) - hypomagnesemia , medicine , magnesium , transplantation , creatinine , ciclosporin , kidney transplantation , diabetes mellitus , gastroenterology , endocrinology , urology , chemistry , organic chemistry
Hypomagnesemia is common after kidney transplantation. Until recently, only the determination of total plasma magnesium was possible, whereas the assessment of ionized magnesium has since become practicable. One hundred and nine renal transplant patients on cyclosporine with allografts functioning stably for more than 6 months and plasma creatinine levels of less than 200 umol/1 entered the study. Total and ionized circulating magnesium were assessed among these 109 patients, as well as among 15 renal transplant patients not on cyclosporine and 21 healthy volunteers. Cyclosporine patients showed significantly lower total and ionized circulating magnesium values than the two control groups. Plasma total and ionized magnesium levels were also significantly lower among cyclosporine patients treated concurrently with insulin or oral hypoglycemic agents than among those who were not. No correlation was noted between time after transplantation and plasma magnesium with respect to patients on cyclosporine. In conclusion, the study demonstrates that a large subset of renal transplant patients treated with cyclosporine have permanent deficiencies of ionized and total magnesium. The tendency towards hypomagnesemia is also more pronounced among patients with diabetes mellitus.